Skip to main content

Table 1 Human clinical isolates of C. jejuni analyzed in the present study

From: Correlations between 23S rRNA genes and erythromycin resistance in Campylobacter jejuni

No.

Isolate no.

Source (Country) (Disease)

Helix 45 IVS (Type)

Erythromycin (MIC)

RAPD

1

81-176

Human (USA)

+ (C)

S

1

2

HP5110

Human (Japan)

S

2

3

HP5122

Human (Japan)

S

2

4

LCDC4483

Human (Canada)

S

2

5

CF-85-46

Human (Japan)

S

3

6

HP5090

Human (Japan)

+ (C)

S

4

7

HP5095

Human (Japan)

± (B)

I

5

8

HP5100

Human (Japan)

+ (D)

S

6

9

HP5096

Human (Japan)

+ (C)

S

7

10

OH4382 (O19)

Human (Japan) (GBS)

+ (B)

S

4

11

86-357

Human (USA)

+ (A)

R (8 μg/ml)

8

12

86-389

Human (USA)

S

5

13

85-3

Human (USA)

+ (B)

I

9

14

D450 (O19)

Human (USA) (GBS)

+ (B)

S

4

15

D3083

Human (USA) (GBS)

+ (B)

R (8 μg/ml)

5

16

MHU003

Human (Japan)

+ (B)

R (16 μg/ml)

4

17

HP5117

Human (Japan)

S

5

18

011220

Unknown

R (8 μg/ml)

4

19

ST23

Human (USA)

I

4

20

CF85-48

Human (Japan)

+ (A)

I

4

21

HP5072

Human (Japan)

+ (B)

I

9

22

HP5083

Human (Japan)

S

10

23

HP5075

Human (Japan)

± (B)

I

4

24

HP4941

Human (Japan)

+ (A)

R (8 μg/ml)

5

25

LMG6444

Human (Belgium)

I

2

26

HP5084

Human (Japan)

+ (A)

S

5

27

84-196

Human (USA) (GBS)

R (8 μg/ml)

4

28

D3468 (O19)

Human (USA) (Diarrhea)

+ (B)

S

4

29

D3215 (O19)

Human (USA) (Diarrhea)

+ (B)

S

4

30

OH4384 (O19)

Human (Japan) (GBS)

+ (B)

S

4

31

D452 (GBS-19, O19)

Human (USA) (GBS)

+ (B)

S

4

32

D445 (O19)

Human (USA) (GBS)

+ (B)

S

4

33

D3141

Human (USA) (Diarrhea)

+ (B)

S

4

34

85-1

Human (USA) (Diarrhea)

S

4

35

84-198 (non GBS non19)

Human (USA) (Diarrhea)

S

8

36

84-194

Human (USA) (Diarrhea)

I

4

37

81116

Human (UK) (Diarrhea)

+ (D)

I

11

38

86-386

Human (USA) (Diarrhea)

S

5

39

84-191

Human (USA) (Diarrhea)

R (8 μg/ml)

5

40

D3002

Human (USA) (Diarrhea)

+ (B)

S

5

41

R

Human (UK) (Diarrhea)

+ (B)

I

5

42

O

Human (UK) (Diarrhea)

I

4

43

M

Human (UK) (Diarrhea)

I

4

44

L

Human (UK) (Diarrhea)

R (8 μg/ml)

2

45

CUM001

Human (USA) (Diarrhea)

+ (B)

S

5

46

79AH88-88

Human (France) (Diarrhea)

+ (A)

S

4

47

D3088

Human (USA) (Diarrhea)

+ (B)

S

5

48

88-84 (85 AC)

Human (France) (Diarrhea)

I

3

49

88-89 (85H)

Human (France) (Diarrhea)

+ (A)

I

2

  1. C Campylobacter, IVS intervening sequence, MIC minimum inhibitory concentration,+ IVS positive, - IVS negative, RAPD random amplified polymorphic DNA, GBS Guillain Barre Syndrome, I intermediate, R resistant, S susceptible